Meta menu:

From here, you can access the Emergencies page, Contact Us page, Accessibility Settings, Language Selection, and Search page.

Open Menu
Ein Stapel medizinischer Bücher.

Selected Publications

Selected Publikations of the Integrative and Antroposophic Medicine Research Group.

You are here:


Thronicke, A., Reinhold, T., von Trott, P., Grah, C., Matthes, B., Matthes, H., Schad, F.:  Cost-effectiveness of real-world administration of chemotherapy and add-on Viscum album L. therapy compared to chemotherapy in the treatment of stage IV NSCLC patients.  PLoS ONE. 2020;15(7):e0236426. Pubmed:

Thronicke, A., Reinhold, T., von Trott, P., Matthes, H., Schad, F.:  Cost-Effectiveness of Real-World Administration of Concomitant Viscum album L. Therapy for the Treatment of Stage IV Pancreatic Cancer.  Evid-Based Compl Alt. 2020;2020:3543568. Pubmed:

Oei, S.L., Thronicke, A., Matthes, H., Schad, F.:  Evaluation of the effects of integrative non-pharmacological interventions on the internal coherence and resilience of breast cancer patients.  Support Care Cancer. 2020. Pubmed:

Oei, S.L., Thronicke, A., Kröz, M., von Trott, P., Schad, F., Matthes, H.:  Impact of Oncological Therapy and Viscum album L Treatment on Cancer-Related Fatigue and Internal Coherence in Nonmetastasized Breast Cancer Patients.  Integr Cancer Ther. 2020;19:1534735420917211. Pubmed:

Diers, J., Wagner, J., Baum, P., Lichthardt, S., Kastner, C., Matthes, N., Matthes, H., Germer, C.T., Löb, S., Wiegering, A.:  Nationwide in-hospital mortality rate following rectal resection for rectal cancer according to annual hospital volume in Germany.  BJS Open. 2020;4(2):310-9. Pubmed:

Matthes, H., Thronicke, A., Hofheinz, R.D., Baars, E., Martin, D., Huber, R., Breitkreuz, T., Bar-Sela, G., Galun, D., Schad, F.:  Statement to an Insufficient Systematic Review on Viscum album L. Therapy.  Evid-Based Compl Alt. 2020;2020:7091039. Pubmed:



Kucharzik, T., Dignass, A.U., Atreya, R., Bokemeyer, B., Esters, P., Herrlinger, K., Kannengießer, K., Kienle, P., Langhorst, J., Lügering, A., Schreiber, S., Stallmach, A., Stein, J., Sturm, A., Teich, N., Siegmund, B., Collaborators::  [August 2019 - AWMF-Registriernummer: 021-009].  Z Gastroenterol. 2019;57(11):1321-405. Pubmed:

Matthes, H., Hofheinz, R.D., Bar-Sela, G., Galun, D., Martin, D., Huber, R., Langhorts, J., Matthiessen, P.F., Schad, F.:  Letter to the editors of the Journal of Cancer Research and Clinical Oncology.  J Cancer Res Clin. 2019;145(9):2405-7. Pubmed:

Diers, J., Wagner, J., Baum, P., Lichthardt, S., Kastner, C., Matthes, N., Löb, S., Matthes, H., Germer, C.T., Wiegering, A.:  Nationwide in-hospital mortality following colonic cancer resection according to hospital volume in Germany.  BJS Open. 2019;3(5):672-7. Pubmed:

Baars, E.W., Zoen, E.B.v., Breitkreuz, T., Martin, D., Matthes, H., von Schoen-Angerer, T., Soldner, G., Vagedes, J., van Wietmarschen, H., Patijn, O., Willcox, M., von Flotow, P., Teut, M., von Ammon, K., Thangavelu, M., Wolf, U., Hummelsberger, J.,...[mehr]   The Contribution of Complementary and Alternative Medicine to Reduce Antibiotic Use: A Narrative Review of Health Concepts, Prevention, and Treatment Strategies.  Evid-Based Compl Alt. 2019;2019:5365608. Pubmed:

Oei, S.L., Thronicke, A., Kröz, M., Matthes, H., Schad, F.:  Use and Safety of Viscum album L Applications in Cancer Patients With Preexisting Autoimmune Diseases: Findings From the Network Oncology Study.  Integr Cancer Ther. 2019;18:1534735419832367. Pubmed:



Thronicke, A., Oei, S.L., Merkle, A., Matthes, H., Schad, F.:  Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients.  Medicines (Basel). 2018;5(3). Pubmed:

Schad, F., Thronicke, A., Merkle, A., Steele, M.L., Kröz, M., Herbstreit, C., Matthes, H.:  Implementation of an Integrative Oncological Concept in the Daily Care of a German Certified Breast Cancer Center.  Complement Med Res. 2018;25(2):85-91. Pubmed:

Thronicke, A., Oei, S.L., Merkle, A., Herbstreit, C., Lemmens, H.P., Grah, C., Kröz, M., Matthes, H., Schad, F.:  Integrative cancer care in a certified Cancer Centre of a German Anthroposophic hospital.  Complement Ther Med. 2018;40:151-7. Pubmed:

Schad, F., Thronicke, A., Steele, M.L., Merkle, A., Matthes, B., Grah, C., Matthes, H.:  Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis.  PLoS ONE. 2018;13(8):e0203058. Pubmed:

Thronicke, A., Kröz, M., Merkle, A., Matthes, H., Herbstreit, C., Schad, F.:  Psychosocial, Cognitive, and Physical Impact of Elaborate Consultations and Life Review in Female Patients with Non-Metastasized Breast Cancer.  Complement Med Res. 2018;25(2):92-101. Pubmed:

Schad, F., Axtner, J., Kröz, M., Matthes, H., Steele, M.L.:  Safety of Combined Treatment With Monoclonal Antibodies and Viscum album L Preparations.  Integr Cancer Ther. 2018;17(1):41-51. Pubmed:

Authors, Collaborators::  [Updated S3-Guideline Colitis ulcerosa. German Society for Digestive and Metabolic Diseases (DGVS) - AWMF Registry 021/009].  Z Gastroenterol. 2018;56(9):1087-169. Pubmed:



Schölmerich, J., Fellermann, K., Seibold, F.W., Rogler, G., Langhorst, J., Howaldt, S., Novacek, G., Petersen, A.M., Bachmann, O., Matthes, H., Hesselbarth, N., Teich, N., Wehkamp, J., Klaus, J., Ott, C., Dilger, K., Greinwald, R., Mueller, R., International TRUST-2 Study Group:  A Randomised, Double-blind, Placebo-controlled Trial of Trichuris suis ova in Active Crohn's Disease.  J Crohn Colitis. 2017;11(4):390-9. Pubmed:

Schad, F., Thronicke, A., Merkle, A., Matthes, H., Steele, M.L.:  Immune-related and adverse drug reactions to low versus high initial doses of Viscum album L. in cancer patients.  Phytomedicine. 2017;36:54-8. Pubmed:

Matthes, H., Jansen, N., Walach, H.:  [Testing the Validity of Biotonisation: An Unconventional Diagnostic Approach].  Complement Med Res. 2017;24(2):114-6. Pubmed:

Hamre, H.J., Glockmann, A., Heckenbach, K., Matthes, H.:  Use and Safety of Anthroposophic Medicinal Products: An Analysis of 44,662 Patients from the EvaMed Pharmacovigilance Network.  Drugs Real World Outcomes. 2017;4(4):199-213. Pubmed:

Kucharzik, T., Wittig, B.M., Helwig, U., Börner, N., Rössler, A., Rath, S., Maaser, C., TRUST study group:  Use of Intestinal Ultrasound to Monitor Crohn's Disease Activity.  Clin Gastroenterol H. 2017;15(4):535-542.e2. Pubmed:



Matthes, H., Buchwald, D., Wispler, M., Kröz, M., Schad, F.:  E. coli Nissle 1917-Suspension zur Behandlung von Patienten mit Clostridium diffizile-assoziierter Diarrhö (CDAD): eine Pilotstudie.  Z Gastroenterol. 2016;54:KV039.

Hagel, S., Fischer, A., Ehlermann, P., Frank, T., Tueffers, K., Sturm, A., Link, A., Demir, M., Siebenhaar, A., Storr, M., Glueck, T., Siegel, E., Solbach, P., Goeser, F., Koelbel, C.B., Lohse, A., Luebbert, C., Kandzi, U., Maier, M., Schuerle, S.,...[mehr]   Fecal Microbiota Transplant in Patients With Recurrent Clostridium Difficile Infection.  Dtsch Arztebl Int. 2016;113(35-36):583-9. Pubmed:

Axtner, J., Steele, M., Kröz, M., Spahn, G., Matthes, H., Schad, F.:  Health services research of integrative oncology in palliative care of patients with advanced pancreatic cancer.  BMC Cancer. 2016;16:579. Pubmed: